Kidney Cancer Association | Advocacy Groups

Newer drugs for kidney cancer have proven extremely effective but can cause unwanted symptoms that affect safety and quality of life.

In recent years, immunotherapy’s usage has expanded for the treatment of patients with kidney cancer.

One patient with stage 4 kidney cancer pivoted from being a journalist to a patient advocate, educating patients and others about a cancer that requires more awareness and research funding.

If an oncologist was apprehensive about Steven Edwards getting a second opinion, that might not be the right doctor for him, the kidney cancer survivor said.

This is a guest post by Joel Stern, who was diagnosed with stage 4 renal cell carcinoma in 2020. This is the second in a two-part series, in which Joel discusses what he learned through his kidney cancer journey.

This is a guest post by Joel Stern, who was diagnosed with stage 4 renal cell carcinoma in 2020. This is the first in a two-part series in which Joel discusses how to take a dire diagnosis and make the best of it.

The Kidney Cancer Association's Medical Director, Sallie McAdoo, MS, CGC, was featured on the "Cancer Interviews" podcast.

2021 was a bumper year for kidney cancer developments, including several new treatment approvals by the FDA and a much better understanding of how kidney cancer is impacted by COVID-19 infections and vaccines.

Marissa Willis is a member of the Kidney Cancer Association’s Patient & Caregiver Advisory Council.

John Ferrell, a member of the KCA’s Patient & Caregiver Advisory Council, spoke about his work as an advocate for kidney cancer and his passion for traveling.

Benjamin Lundin is a member of the Kidney Cancer Association’s Patient & Caregiver Advisory Council.

A woman details her father's journey with kidney cancer.

Last week, the KCA hosted its very first live streaming event! The KCA’s Medical Director Sallie McAdoo, MS, CGC, moderated a Facebook Live conversation on the basics of clinical trials.

Welcome to our new series where we take a look at what’s happening in kidney cancer each month! From treatments and clinical trials to genetic testing and government regulations, the KCA’s Medical Director, Sallie McAdoo, MS, CGC, will show you what’s new and why it matters.

In June 2020, Kayla Bulkley gave birth to her and her husband’s long-awaited baby girl, Jane. Within a month, Kayla was diagnosed with kidney cancer.

The Kidney Cancer Association, alongside the American Urological Association and a group of kidney cancer-focused advocacy organizations, wrote this week to congratulate then-President-elect Joe Biden and urge him to make the needs of people impacted by kidney cancer and kidney cancer research a top priority for the incoming administration.

Welcome to the KCA's new series where they take a look at what’s happening in kidney cancer each month! From treatments and clinical trials to genetic testing and government regulations, the KCA’s Medical Director, Sallie McAdoo, MS, CGC, will show you what’s new and why it matters.

With the second COVID-19 vaccine receiving emergency use authorization by the FDA, patients with cancer undergoing treatment should keep in mind how it may affect their therapy and the potential difference between the two vaccines by Pfizer-BioNTech and Moderna.

Getting kidney cancer treatment during the COVID-19 pandemic.

Kidney cancer positives that might come from this pandemic.

How kidney cancer affects the risks of coronavirus.

A message from the KCA’s CEO and President about COVID-19.

Kidney cancer changed how Tracie saw her world.

On his motorcycle, Stewy rides for kidney cancer.

A clinical trial and a positive attitude helped Bill Brown ring the bell.

Dawne Gee worked hard to get answers about her kidney cancer.

“Those who are doing well and are stable in terms of safety and tolerability can come into the office less often,” Dr. David R. Spigel, said. “(This is) a big win.”